Genexine Market Cap

Genexine has a market cap or net worth of 201.02 billion as of February 6, 2026. Its market cap has decreased by -21.35% in one year.

Market Cap

201.02B

Enterprise Value

n/a

Revenue

5.81B

Ranking

n/a

PE Ratio

n/a

Stock Price

4,420.00

Market Cap Chart

Since September 15, 2009, Genexine's market cap has increased from 109.02B to 201.02B, an increase of 84.39%. That is a compound annual growth rate of 3.80%.

Market Cap History

Date	Market Cap	% Change
Feb 6, 2026	201.02B	-5.66%
Dec 30, 2025	213.07B	-12.27%
Dec 30, 2024	242.86B	-40.82%
Dec 28, 2023	410.35B	-12.73%
Dec 29, 2022	470.21B	-67.78%
Dec 30, 2021	1.46T	-52.47%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
JETEMA,	348.91B
Bioneer	325.98B
Helixmith	279.04B
EASY BIO,Inc.	248.78B
HLB Therapeutics	241.80B
MedPacto	193.65B
Macrogen	188.10B
ENCell	181.90B

Market Cap Rankings